CELLECTAR BIOSCIENCES, INC.
🏢 View company profile →8Patents
8Active
8Granted
44Portfolio score
Filing activity: Sep 23, 2014 → Feb 12, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9345718B1 | Phospholipid ether analogs as cancer-targeting drug vehicles | Chemistry; Metallurgy | 9 | Active |
| US9480754B2 | Phospholipid ether analogs as cancer-targeting drug vehicles | Chemistry; Metallurgy | 7 | Active |
| US9616140B2 | Fluorescent phospholipid ether compounds, compositions, and methods of use | Human Necessities | 2 | Active |
| US9925269B2 | Phospholipid ether analogs as cancer-targeting drug vehicles | Chemistry; Metallurgy | 1 | Active |
| US9550002B2 | Phospholipid analogs as diapeutic agents and methods thereof | Chemistry; Metallurgy | 1 | Active |
| US11467159B2 | Luminescent phospholipid analogs for the identification and isolation of circulating tumor cells | Physics | 0 | Active |
| US9579406B2 | Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof | Physics | 0 | Active |
| US11439709B2 | Phospholipid ether analogs as cancer-targeting drug vehicles | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.